TimesSquare Capital Management, LLC
Source: SEC Form 13F · as of Mar 2026TimesSquare Capital Management, LLC holds 19 biotech & pharma companies tracked by BioSniper, totaling $676.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$676.9M
| Company | Shares | Value |
|---|---|---|
| CORCencora Inc. | 422,070 | $132.6M |
| INSMINSMED Inc | 584,798 | $95.6M |
| IDXXIDEXX LABORATORIES INC /DE | 163,763 | $92.0M |
| ARGXARGENX SE | 83,117 | $60.7M |
| RGENREPLIGEN CORP | 456,083 | $53.7M |
| MIRMMirum Pharmaceuticals, Inc. | 376,473 | $34.8M |
| KRYSKrystal Biotech, Inc. | 112,342 | $29.0M |
| TARSTarsus Pharmaceuticals, Inc. | 388,590 | $27.3M |
| NAMSNEWAMSTERDAM PHARMA CO N.V. | 751,988 | $24.1M |
| XENEXenon Pharmaceuticals Inc. | 359,293 | $20.9M |
| IONSIONIS PHARMACEUTICALS INC | 275,674 | $20.7M |
| VCELVericel Corp | 578,333 | $18.6M |
| CGONCG Oncology, Inc. | 253,708 | $17.2M |
| KYMRKymera Therapeutics, Inc. | 168,846 | $14.1M |
| ABVXAbivax SA | 109,183 | $12.2M |
| VERAVera Therapeutics, Inc. | 232,463 | $9.4M |
| MLYSMineralys Therapeutics, Inc. | 338,798 | $9.2M |
| COGTCogent Biosciences, Inc. | 85,000 | $3.3M |
| ELVNEnliven Therapeutics, Inc. | 45,000 | $1.8M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.